Immatics N.V. (IMTX) stock
IMTXNasdaqBiological Products, (No Diagnostic Substances)Fiscal year ends December 31
$5.95−0.15 (-2.46%)
Close on Nov 19, 2026Market cap $797.73MP/E –Yield –
Immatics shares outstanding
Diluted shares outstanding: the weighted share count used for earnings per share, adjusted for stock splits.
Immatics's shares outstanding was 137M at Jun 30, 2026. For fiscal 2025 it was 122M, up 14.6% from the year before. The highest annual figure on record is 122M in fiscal 2025.
Annual shares outstanding
| Period | Period end | Value | Change |
|---|---|---|---|
| FY2025 | Dec 31, 2025 | 122M | +14.6% |
| FY2024 | Dec 31, 2024 | 107M | +32.6% |
| FY2023 | Dec 31, 2023 | 81M | +17.0% |
| FY2022 | Dec 31, 2022 | 69M | +9.4% |
| FY2021 | Dec 31, 2021 | 63M | +31.1% |
| FY2020 | Dec 31, 2020 | 48M | +45.0% |
| FY2019 | Dec 31, 2019 | 33M | 0.0% |
| FY2018 | Dec 31, 2018 | 33M | – |
Quarterly shares outstanding
Change is against the same quarter a year earlier.
| Period | Period end | Value | Change |
|---|---|---|---|
| Q2 FY2026 | Jun 30, 2026 | 137M | +32.6% |
| Q2 FY2025 | Jun 30, 2025 | 122M | +14.8% |
| Q4 FY2024 | Dec 31, 2024 | 115M | +48.8% |
| Q3 FY2024 | Sep 30, 2024 | 110M | +69.9% |
| Q2 FY2024 | Jun 30, 2024 | 103M | +63.8% |
| Q1 FY2024 | Mar 31, 2024 | 106M | +220.1% |
| Q2 FY2023 | Jun 30, 2023 | 77M | – |
| Q2 FY2022 | Jun 30, 2022 | 65M | – |
| Q2 FY2021 | Jun 30, 2021 | 63M | – |
| Q2 FY2020 | Jun 30, 2020 | 33M | – |
See a number that looks wrong?